Please use this identifier to cite or link to this item: https://elar.urfu.ru/handle/10995/144208
Title: Developing Novel Experimental Models of m-TORopathic Epilepsy and Related Neuropathologies: Translational Insights from Zebrafish
Authors: de, Abreu, M. S.
Demin, K. A.
Kotova, M. M.
Mirzaei, F.
Shariff, S.
Kantawala, B.
Zakharchenko, K. V.
Kolesnikova, T. O.
Dilbaryan, K.
Grigoryan, A.
Yenkoyan, K. B.
Kalueff, A. V.
Issue Date: 2023
Publisher: MDPI
Citation: De Abreu, M. S., Demin, K. A., Kotova, M. M., Mirzaei, F., Shariff, S., Kantawala, B., Zakharchenko, K. V., Kolesnikova, T. O., Dilbaryan, K., Grigoryan, A., Yenkoyan, K. B., & Kalueff, A. V. (2023). Developing Novel Experimental Models of m-TORopathic Epilepsy and Related Neuropathologies: Translational Insights from Zebrafish. International Journal of Molecular Sciences, 24(2), [1530]. https://doi.org/10.3390/ijms24021530
De Abreu, MS, Demin, KA, Kotova, MM, Mirzaei, F, Shariff, S, Kantawala, B, Zakharchenko, KV, Kolesnikova, TO, Dilbaryan, K, Grigoryan, A, Yenkoyan, KB & Kalueff, AV 2023, 'Developing Novel Experimental Models of m-TORopathic Epilepsy and Related Neuropathologies: Translational Insights from Zebrafish', International Journal of Molecular Sciences, Том. 24, № 2, 1530. https://doi.org/10.3390/ijms24021530
Abstract: The mammalian target of rapamycin (mTOR) is an important molecular regulator of cell growth and proliferation. Brain mTOR activity plays a crucial role in synaptic plasticity, cell development, migration and proliferation, as well as memory storage, protein synthesis, autophagy, ion channel expression and axonal regeneration. Aberrant mTOR signaling causes a diverse group of neurological disorders, termed ‘mTORopathies’. Typically arising from mutations within the mTOR signaling pathway, these disorders are characterized by cortical malformations and other neuromorphological abnormalities that usually co-occur with severe, often treatment-resistant, epilepsy. Here, we discuss recent advances and current challenges in developing experimental models of mTOR-dependent epilepsy and other related mTORopathies, including using zebrafish models for studying these disorders, as well as outline future directions of research in this field.
Keywords: ANIMAL MODEL
MTOR
MTOROPATHY
SIGNALING PATHWAY
ZEBRAFISH
ANIMALS
DISEASE MODELS, ANIMAL
EPILEPSY
MAMMALS
SIGNAL TRANSDUCTION
TOR SERINE-THREONINE KINASES
ZEBRAFISH
ION CHANNEL
MAMMALIAN TARGET OF RAPAMYCIN
TARGET OF RAPAMYCIN KINASE
ANIMAL MODEL
AUTOPHAGY (CELLULAR)
BEHAVIOR DISORDER
CELL DIFFERENTIATION
EXPERIMENTAL MODEL
HUMAN
MTOR SIGNALING
MTOROPATHY
MYELINATION
NERVE CELL DIFFERENTIATION
NERVE CELL PLASTICITY
NERVE SPROUTING
NERVOUS SYSTEM
NERVOUS SYSTEM DEVELOPMENT
NEUROPATHOLOGY
NONHUMAN
PROTEIN FUNCTION
RECURRENT DISEASE
REGULATORY MECHANISM
REVIEW
RODENT MODEL
ZEBRA FISH
ANIMAL
DISEASE MODEL
EPILEPSY
GENETICS
MAMMAL
METABOLISM
SIGNAL TRANSDUCTION
ZEBRA FISH
URI: https://elar.urfu.ru/handle/10995/144208
Access: info:eu-repo/semantics/openAccess
cc-by
License text: https://creativecommons.org/licenses/by/4.0/
SCOPUS ID: 85146776820
WOS ID: 000917726400001
PURE ID: 33342459
ISSN: 1422-0067
1661-6596
DOI: 10.3390/ijms24021530
Sponsorship: YSMU; Ministry of Education and Science of the Russian Federation, Minobrnauka; European Union-funded H2020; Horizon 2020 Framework Programme, H2020, (857600); State Committee of Science, SCS, (20TTCG-3A012, N10-14/I-1)
Funding text 1: The study was performed by selected students and staff of YSMU COBRAIN Scientific-Educational Center for Fundamental Brain Research with support from the Republic of Armenia State Committee of Science (20TTCG-3A012 and N10-14/I-1) and the European Union-funded H2020 COBRAIN project (857600). ; Funding text 2: The publication research was supported by the Ministry of Science and Higher Education of the Russian Federation (Ural Federal University Program of Development within the Priority-2030 Program).
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-85146776820.pdf1,93 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons